- Home
- LASE vs ABVC Comparison
LASE vs ABVC Comparison
Compare LASE & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LASE | ABVC |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.0M | 50.5M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | LASE | ABVC |
|---|---|---|
| Price | $2.02 | $2.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 623.3K | 53.7K |
| Earning Date | 12-23-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,140,614.00 | $797,916.00 |
| Revenue This Year | N/A | $735.18 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 132.01 | 56.52 |
| 52 Week Low | $1.71 | $0.40 |
| 52 Week High | $6.77 | $5.48 |
Technical Indicators
Market Signals| Indicator | LASE | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 43.55 |
| Support Level | $2.03 | $2.00 |
| Resistance Level | $2.70 | $2.20 |
| Average True Range (ATR) | 0.16 | 0.12 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 5.56 | 32.35 |
Price Performance
Historical ComparisonAbout LASE Laser Photonics Corporation
Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.